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ABSTRAK 
 
Seorang pesakit sindrom Rothmund-Thomson (RTS) yang berusia 27 tahun telah di 
diagnosa dengan kanser sel skuamus dasar lidah. Keabnormalan mekanisma 
pemulihan DNA pada sebahagian pesakit RTS mendorong mereka untuk mendapat 
kanser dan keadaan ini juga mempengaruhi toleren kepada rawatan radioterapi yang 
diberikan. 
 
Kata kunci:  sindrom Rothmund-Thomson (RTS), kanser sel skuamus dasar lidah, 
toksisiti radioterapi 
 
 
ABSTRACT  
 
We report a case of squamous cell carcinoma of the base of the tongue in a 27 years 
old patient with Rothmund-Thomson syndrome (RTS). An abnormal DNA repair 
mechanism in some RTS patients predispose them to malignancy and influence the 
tolerance to radiotherapy. 
 
Key words:  Rothmund-Thomson syndrome, squamous cell carcinoma tongue, 
radiation toxicity 
 
 
 
INTRODUCTION  
 
Rothmund-Thomson syndrome (RTS 
[MIM #268400]) is a rare and severe au-
tosomal recessive genodermatosis. It 
was first reported in 1868 in a patient 
with cataract and progressive poikilo-
derma by the German opthalmologist 
Rothmund and subsequently by the 
British dermatologist, Thomson with the 
current eponym introduced in 1957 
(Taylor 1957). RTS is diagnosed clinically 
and the main features include proportio-
nate dwarfism, premature ageing, skin 
hyperpigmentation appearing within the 
first semester of life and longlife persist-
ing, poikiloderma, telangiectasia, brittle 
hair sometimes progressing to total alo-
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pecia, dystrophic nails, juvenile cataract, 
photosensitivity and congenital skeletal 
defects as hypoplasia or absence of the 
radii and thumbs. There is a higher than 
expected incidence of cutaneous and 
non-cutaneous malignancies particularly 
osteosarcoma (Vennos et al. 1992, Wang 
et al. 2001). Several RTS patients have 
been described to have two malignancies 
including osteosarcoma and lymphoma 
(Wang et al. 2001).  
Mutations in helicase RECQ4 gene are 
responsible for a subset of cases of RTS. 
The RECQ4 gene structure is unusual 
because it contains many small introns 
<100bp. Wang et al. (2002) described a 
proband with RTS who had a novel 11-bp 
intronic deletion and showed that this 
mutation results in a 66-bp intron too 
small for proper slicing. Constraint on 
intron size may represent a general mu-
tational mechanism in RTS (Wang et al. 
2002). This patient and his non-identical 
twin sister both had a homozygous muta-
tion of the RECQ4 gene which is respon-
sible for the severe phenotype asso-
ciated with RTS (Balraj et al. 2002). The 
twin sister developed osteosarcoma of 
the left humerus at the age of 15. She 
received chemotherapy and underwent 
limb salvage surgery. However, she de-
veloped metastases in her lungs and 
succumbed to the disease. 
Response to radiotherapy in RTS pa-
tients has been variable. An abnormal 
DNA repair mechanism in some RTS 
patients predisposes them to malignancy 
and influence the tolerance of radiothe-
rapy. We are aware of three previous 
reports of patients with RTS developing 
squamous cell carcinoma (SCC) of the 
tongue (Borg et al. 1998, Martin-Bertolin 
et al. 1998, Dahele et al. 2004). A patient 
was reported to develop increased radio-
sensitivity and tissue intolerance to che-
motherapy (Borg et al. 1998) while 
another patient was reported to tolerate 
radiotherapy without evidence of in-
creased morbidity (Dahele et al. 2004). In 
this report, we describe a patient with a 
history of osteosarcoma who developed 
SCC of the base of the tongue. He un-
derwent a course of radiotherapy for the 
SCC of the tongue. 
 
CASE REPORT 
 
The patient is a 27 year-old male, the first 
twin of a set of non-identical twins. The 
twins first presented with clinical features 
of RTS at the age of 10 months. Four 
generation pedigree showed a high de-
gree of consanguinity, and the parents 
are first cousins. Molecular analysis 
showed a homozygous mutation in 
RECQ4 helicase: 2746-2756-
delTGGGCTGAGGC in IVS8 which is 
responsible for the severe phenotype 
associated with RTS in both twins, while 
both parents and the grandmothers were 
heterozygous. These findings were re-
ported previously by Balraj et al. (2002). 
The patient developed multicentric os-
teosarcoma of the left humerus and right 
upper tibia at the age of 14 years. The 
tumor in the right upper tibia was re-
sected and allogenic bone grafting was 
performed. Subsequently, he received 
chemotherapy and later limb salvage 
surgery was performed for the tumor in 
the left humerus. However, he had to 
undergo an above knee amputation of 
the right leg as the site of the bone graft 
was infected with avascular necrosis and 
detachment of the proximal part of the 
bone graft. He did not receive radiothe-
rapy during the treatment for osteosar-
coma. He was disease-free for 10 years 
following therapy.  
On follow-up he was noted to have right 
submandibular lymphadenopathy of 
2.5cm x 2.0cm but defaulted referral for a 
biopsy. Three months later he was ad-
mitted for enlarging right neck swelling 
associated with right tongue pain and 
difficulty in eating. There was a history of 
intermittent fever, lethargy, and loss of 
weight (height 141.5cm, weight dropped  
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Figure 1: There is an ulcer at the right side of the 
posterior base of the tongue. 
 
from 26.3kg to 25.1kg, BMI dropped from 
13.2 to 12.6). Physical examination re-
vealed a 3.0cm x 3.5cm ulcer at the right 
side of the posterior base of his tongue 
(Figure 1). Biopsy of the ulcer confirmed 
the presence of a well-differentiated SCC 
(Figure 2). It was staged as T2N2CM0 
according to the 1998 American Joint 
Committee on Cancer (AJCC) staging 
system (American Joint Committee on 
Cancer, 1998).  
Tumor excision was not performed in 
view of the extension of the tumor and 
his poor clinical condition. The patient 
was then advised for radiotherapy. In the 
first phase of radiotherapy the primary 
tumor and neck was treated to a total 
dose of 40 Gy in 20 fractions at 2.0 Gy 
per fraction. The patient developed se-
vere mucositis requiring regular intraven-
ous morphine, oral toilet and liquid nutri-
tional supplement and the treatment 
schedule was interrupted. After introduc-
tion of spinal cord shielding in the second 
phase of treatment, the primary tumor 
and neck was boosted with a further 26 
Gy in 13 fractions. Subsequently the right 
neck was treated with a boost of 10 Gy in 
5 fractions. The overall treatment time 
was extended to 63 days from a planned 
42 days because of toxicity-related 
breaks and patient non-compliance. The 
tumor size reduced to approximately 
0.5cm x 0.5cm at completion of radiothe-
rapy. The patient developed severe mu-
cositis with skin desquamation in the 
treated area (Figure 3) following treat-
ment. Local site infection was success-
fully treated with antibiotics. The toxicity 
symptoms subsided two months after 
completion of radiotherapy. Unfortunately, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The section shows islands of well-differentiated squamous cell carcinoma (Hematoxylin and eosin 
stain, x40). 
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Figure 3: Radiation-induced cutaneous reaction 
with inflamed skin, hyperpigmentation and areas of 
skin breaks in the neck after completion of treatment. 
 
the tumor recurred and the patient died 
16 months after diagnosis of SCC. 
 
DISCUSSION 
 
We believe that in our patient, the severe 
phenotype was responsible for the mul-
tiple malignancies. In addition, being a 
chronic cigarette smoker increased his 
relative risk of SCC in the tongue. Can-
cers of the head and neck show a strong 
association with alcohol consumption and 
smoking, particularly cigarettes. This 
patient however did not have a history of 
alcoholism. The severe phenotype, 
chronic cigarette smoking, and previous 
chemotherapy for treatment of osteosar-
coma had most likely played a role in the 
pathogenesis of the tongue cancer in this 
patient. 
In addition, we found that our patient 
had a severe toxicity from radiotherapy. 
A similar finding was reported by Borg et 
al. (1998) in a patient with an advanced 
tumor who had greater than expected 
postoperative radiotherapy toxicity, and 
the dose per fraction as well as the total 
dose was reduced (from 1.8 to 1.65 Gy 
per fraction and total dose from 66.6 Gy 
to 58.55 Gy). The treatment time in this 
report was also extended from 45 to 71 
days as a result of the toxicity. In 
contrast, Dahele et al. (2004) described a 
patient with SCC of the tongue who 
tolerated postoperative radiotherapy well, 
without evidence of increased early or 
late radiation morbidity. The patient 
received radiotherapy at a total dose of 
50 Gy in 25 fractions over 5 weeks 
without undue toxicity. Given the 
heterogeneity in the syndrome, it is 
possible that patients’ susceptibility to 
radiation toxicity also varies. Reports on 
abnormal DNA repair after irradiation in 
RTS could explain for excess treatment 
toxicity in some patients.  
Recently, Hicks et al. (2007) reported 
that the clinical behaviour of patients with 
RTS and osteosarcoma is similar to pa-
tients with sporadic osteosarcoma, and 
suggested that these patients should 
initially be treated with conventional 
doses of chemotherapy as prescribed by 
current protocols. However, five patients 
were reported to require chemotherapy 
dose modifications, most commonly due 
to mucositis from doxorubicin (Hicks et 
al. 2007). Therefore, careful clinical ob-
servation is needed to monitor for en-
hanced doxorubicin sensitivity in RTS 
patients. It is apparent that some RTS 
patients have abnormal DNA repair me-
chanisms that could lead to increased 
toxicity to radiotherapy and chemothe-
rapy. Therefore a complete screening for 
malignancies of RTS patients are impor-
tant to identify those patients who are 
prone to develop cancer and are there-
fore likely to experience increase treat-
ment morbidities. The present case illu-
strates the importance of regular follow-
up of all RTS patients and screening 
those who are prone to develop cancer. 
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